About
Drug Discovery
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (10)
View allTotal Trials
10
As Lead Sponsor
10
As Collaborator
0
Total Enrollment
367
By Phase
PHASE1: 8PHASE2: 1
By Status
COMPLETED: 10
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT05684705Lead Sponsor
Study to Investigate the Penetration of Rifabutin Into the Lung After Multiple Intravenous Administrations of BV100
PHASE1Completed
35 participants
Started: Sep 1, 2023 · Completed: Dec 30, 2024
NCT05685615Lead Sponsor
PK of BV100 in Patients VABP Suspected or Confirmed to Be Due to CRAB
PHASE2Completed
39 participants
Started: Apr 20, 2023 · Completed: Dec 11, 2024
NCT05684718Lead Sponsor
To Evaluate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of BV100
PHASE1Completed
16 participants
Started: Feb 1, 2023 · Completed: Oct 31, 2023
NCT05537142Lead Sponsor
A Study to Assess the Phamacokinetics of BV100 in Participants with Varying Degrees of Hepatic Impairment
PHASE1Completed
33 participants
Started: Sep 2, 2022 · Completed: Oct 30, 2024
NCT05537090Lead Sponsor
A Study to Assess Effect of BV100 on the Pharmacokinetics of Midazolam in Healthy Participants
PHASE1Completed
16 participants
Started: Sep 1, 2022 · Completed: Sep 30, 2023
Locations (1)
Headquarters
Basel, Switzerland
Map
Loading map...